In recent years, transcatheter intervention techniques have emerged as a promising alternative for the closure of perimembranous ventricular septal defect (VSD). The advancements in trancatheter VSD ...

Chicago, IL - A nonrandomized trial of a new ventricular septal occluder designed specifically for the closure of defects that occur post-MI suggests that while mortality is still high following the ...

September 18, 2007 — The US Food and Drug Administration (FDA) has granted 510(k) clearance to 2 flexible digital endoscopes for diagnostic and therapeutic procedures and to a short-term catheter for ...

A novel catheter technique for patching holes in the heart may make it possible for many patients to avoid surgery altogether and others to regain enough strength to safely undergo surgical repair at ...

Perimembranous ventricular septal defects (VSDs) involving the membranous septum and the adjoining muscular septum are the most common form of congenital heart defect. Traditional surgical repair ...

Schaffhausen, Switzerland. Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained European CE Mark approval for its dedicated muscular ...

Muscular ventricular septal defects (mVSD) appearing together with other septal defects are frequently regarded as ‘concomitant’ pathologies, that nevertheless should be considered while the patient ...

(MENAFN- Market Press Release) June 10, 2025 3:02 am - Industry revenue for Transcatheter Vsd Occluder is estimated to rise to $1257.6 million by 2035 from $528.5 million of 2024. The revenue growth ...

After bicuspid aortic valve, ventricular septal defects (VSDs) are the most common congenital heart abnormalities. Of all congenital defects, around 20% are solitary lesions and another 10% are ...

(May 10, 2007—ORLANDO, FL)—A novel catheter technique for patching holes in the heart may make it possible for many patients to avoid surgery altogether and others to regain enough strength to safely ...